4.4 Article

DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans

Journal

INFECTION AND IMMUNITY
Volume 84, Issue 6, Pages 1879-1886

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/IAI.00222-16

Keywords

-

Funding

  1. HHS \ National Institutes of Health (NIH) [R01 AI093808, R21 AI105617, P30 CA008748]
  2. Burroughs Wellcome Fund (BWF)
  3. Stony Wold-Herbert Fund, Inc.
  4. Dana Foundation (MSKCC Clinical Scholars Biomedical Research Training Program fellowship)

Ask authors/readers for more resources

Cryptococcus neoformans is an opportunistic fungal pathogen that is inhaled into the lungs and can lead to life-threatening meningoencephalitis in immunocompromised patients. Currently, the molecular mechanisms that regulate the mammalian immune response to respiratory cryptococcal challenge remain poorly defined. DAP12, a signaling adapter for multiple pattern recognition receptors in myeloid and natural killer (NK) cells, has been shown to play both activating and inhibitory roles during lung infections by different bacteria and fungi. In this study, we demonstrate that DAP12 plays an important inhibitory role in the immune response to C. neoformans. Infectious outcomes in DAP12(-/-) mice, including survival and lung fungal burden, are significantly improved compared to those in C57BL/6 wild-type (WT) mice. We find that eosinophils and macrophages are decreased while NK cells are increased in the lungs of infected DAP12(-/-) mice. In contrast to WT NK cells, DAP12(-/-) NK cells are able to repress C. neoformans growth in vitro. Additionally, DAP12(-/-) macrophages are more highly activated than WT macrophages, with increased production of tumor necrosis factor (TNF) and CCL5/RANTES and more efficient uptake and killing of C. neoformans. These findings suggest that DAP12 acts as a brake on the pulmonary immune response to C. neoformans by promoting pulmonary eosinophilia and by inhibiting the activation and antifungal activities of effector cells, including NK cells and macrophages.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

Rapid transcriptional and metabolic adaptation of intestinal microbes to host immune activation

Simone Becattini, Matthew T. Sorbara, Sohn G. Kim, Eric L. Littmann, Qiwen Dong, Gavin Walsh, Roberta Wright, Luigi Amoretti, Emily Fontana, Tobias M. Hohl, Eric G. Pamer

Summary: In response to acute immune activation, gut microbiota rapidly changes gene transcription and metabolite production, without affecting their relative abundance. Different immune stimuli can induce similar transcriptional profiles in commensal bacteria.

CELL HOST & MICROBE (2021)

Article Immunology

The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection

Allen W. Zhang, Sejal Morjaria, Anna Kaltsas, Tobias M. Hohl, Rekha Parameswaran, Dhruvkumar Patel, Wei Zhou, Jacqueline Predmore, Rocio Perez-Johnston, Justin Jee, Anthony F. Daniyan, Miguel-Angel Perales, Ying Taur

Summary: The use of G-CSF in cancer patients with COVID-19 may increase the risk of hospitalization, respiratory failure, and death. Careful consideration should be given to the potential risks and benefits of G-CSF treatment in neutropenic cancer patients with COVID-19.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Clinical and Genomic Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infections in mRNA Vaccinated Health Care Personnel in New York City

Elizabeth Robilotti, Karissa Whiting, Anabella Lucca, Chester Poon, Rebecca Guest, Tracy McMillen, Krupa Jani, Alexander Solovyov, Suzanne Kelson, Kevin Browne, Scott Freeswick, Tobias M. Hohl, Deborah Korenstein, Denis Ruchnewitz, Michael Lassig, Marta Luksza, Benjamin Greenbaum, Venkatraman E. Seshan, N. Esther Babady, Mini Kamboj

Summary: A study of over 13000 healthcare personnel (HCP) showed that messenger RNA (mRNA) vaccine effectiveness (VE) against coronavirus disease 2019 (COVID-19) was 94% through initial 5 months of follow-up, with moderate VE reduction to 75% during subsequent Delta-dominant period. No hospitalizations occurred among vaccinated HCP throughout the study period.

CLINICAL INFECTIOUS DISEASES (2022)

Article Genetics & Heredity

Identification of a novel Candida metapsilosis isolate reveals multiple hybridization events

Caoimhe E. O'Brien, Bing Zhai, Mihaela Ola, Sean A. Bergin, Eoin O. Cinneide, Isla O'Connor, Thierry Rolling, Edwin Miranda, N. Esther Babady, Tobias M. Hohl, Geraldine Butler

Summary: The Candida metapsilosis AC isolate, originating from a separate hybridization event, is different from the AB isolates, as it has not undergone introgression at the mating type-like locus and is in the early stages of genome stabilization.

G3-GENES GENOMES GENETICS (2022)

Article Medicine, Research & Experimental

Customization of a DADA2-based pipeline for fungal internal transcribed spacer1 (ITS1) amplicon data sets

Thierry Rolling, Bing Zhai, John Frame, Tobias M. Hohl, Ying Taur

Summary: Identification and analysis of fungal communities commonly rely on ITS-based amplicon sequencing. In this study, a customized DADA2-based pipeline was used to achieve high-resolution inference of fungal constituents. Quality filtering, sequencing bias, and database selection were identified as key variables determining the accuracy of sample inference. By fine-tuning the filtering process and introducing a wobble nucleotide, the representation of fungal communities was improved. Additionally, a BLAST-based algorithm showed higher reliability in species-level taxonomic annotation compared with the naive Bayesian classifier implemented in DADA2.

JCI INSIGHT (2022)

Article Oncology

Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation

Roni Shouval, Nicholas R. Waters, Antonio L. C. Gomes, Corrado Zuanelli Brambilla, Teng Fei, Sean M. Devlin, Chi L. Nguyen, Kate A. Markey, Anqi Dai, John B. Slingerland, Annelie G. Clurman, Emily Fontana, Luigi A. Amoretti, Roberta J. Wright, Tobias M. Hohl, Ying Taur, Anthony D. Sung, Daniela Weber, Daigo Hashimoto, Takanori Teshima, Nelson J. Chao, Ernst Holler, Michael Scordo, Sergio A. Giralt, Miguel-Angel Perales, Jonathan U. Peled, Marcel R. M. van den Brink

Summary: We investigated the relationship between gut microbiota disruption and preparative conditioning regimens in allogeneic hematopoietic cell transplantation (allo-HCT) recipients. Our findings suggest that high-intensity conditioning regimens are associated with the most severe microbiota injury, while non-myeloablative regimens are associated with mild injury. Pretransplant microbial compositions are best preserved with certain conditioning regimens, while others result in loss of commensal bacteria and expansion of Enterococcus.

CLINICAL CANCER RESEARCH (2023)

Article Microbiology

Systematic Analysis of Copy Number Variations in the Pathogenic Yeast Candida parapsilosis Identifies a Gene Amplification in RTA3 That is Associated with Drug Resistance

Sean A. Bergin, Fang Zhao, Adam P. Ryan, Carolin A. Muller, Conrad A. Nieduszynski, Bing Zhai, Thierry Rolling, Tobias M. Hohl, Florent Morio, Jillian Scully, Kenneth H. Wolfe, Geraldine Butler

Summary: We analyzed the genomes of 170 C. parapsilosis isolates and identified multiple copy number variations (CNVs). We found that the increased copy number of the RTA3 gene is associated with resistance to the drug miltefosine. Additionally, we discovered that mutations in flippase genes can also contribute to resistance.
Article Genetics & Heredity

The future of fungi: threats and opportunities

Nicola T. Case, Judith Berman, David S. Blehert, Robert A. Cramer, Christina Cuomo, Cameron R. Currie, Iuliana Ene, Matthew C. Fisher, Lillian K. Fritz-Laylin, Aleeza C. Gerstein, N. Louise Glass, Neil A. R. Gow, Sarah J. Gurr, Chris Todd Hittinger, Tobias M. Hohl, Iliyan D. Iliev, Timothy Y. James, Hailing Jin, Bruce S. Klein, James W. Kronstad, Jeffrey M. Lorch, Victoria McGovern, Aaron P. Mitchell, Julia A. Segre, Rebecca S. Shapiro, Donald C. Sheppard, Anita Sil, Jason E. Stajich, Eva E. Stukenbrock, John W. Taylor, Dawn Thompson, Gerard D. Wright, Joseph Heitman, Leah E. Cowen

Summary: The fungal kingdom has diverse impacts on animal, plant, and ecosystem health, supporting life while also causing diseases. With increased climate change, antimicrobial resistance, and other global challenges, it is crucial to develop new approaches to combat fungal threats and harness their potential. This report provides recommendations and highlights major research advances and ideas discussed at a workshop to address these challenges.

G3-GENES GENOMES GENETICS (2022)

Article Immunology

Cutting Edge: Neutrophils License the Maturation of Monocytes into Effective Antifungal Effectors

Vanessa Espinosa, Orchi Dutta, Lena J. Heung, Keyi Wang, Yun-Juan Chang, Patricia Soteropoulos, Tobias M. Hohl, Mark C. Siracusa, Amariliz Rivera

Summary: This study reveals that neutrophils play a critical role in antifungal immunity by not only directly eliminating Aspergillus fumigatus conidia, but also by contributing to the activation of protective antifungal monocytes. This contribution is achieved, in part, through the regulation of STAT1-dependent functions.

JOURNAL OF IMMUNOLOGY (2022)

Review Immunology

Immunity to fungi in the lung

Lena J. Heung, Darin L. Wiesner, Keyi Wang, Amariliz Rivera, Tobias M. Hohl

Summary: The respiratory tree plays a crucial role in maintaining sterilizing immunity against fungal pathogens. Fungal pneumonia usually occurs in individuals with compromised immune systems, such as HIV/AIDS patients, organ transplant recipients, and those undergoing corticosteroids treatment. Additionally, respiratory viruses and medical therapies used to treat viral infections can impair the lung's immune defense against fungi. Understanding lung-specific antifungal immunity has the potential to improve diagnostic, preventive, therapeutic, and vaccine strategies against fungal diseases of the lung.

SEMINARS IN IMMUNOLOGY (2023)

Article Immunology

Dectin-1/CARD9 induction of the TFEB and TFE3 gene network is dispensable for phagocyte anti-Aspergillus activity in the lung

Mariano A. Aufiero, Neta Shlezinger, Mergim Gjonbalaj, Kathleen A. M. Mills, Andrea Ballabio, Tobias M. Hohl

Summary: Research has shown that myeloid phagocytes activate TFEB and TFE3 in response to Aspergillus fumigatus infection, which is crucial for lung immunity. However, genetic loss of TFEB and TFE3 does not significantly impact fungal control and host survival.

INFECTION AND IMMUNITY (2023)

Article Microbiology

Aspergillus fumigatus cytochrome c impacts conidial survival during sterilizing immunity

Matthew R. James, Mariano A. Aufiero, Elisa M. Vesely, Sourabh Dhingra, Ko-Wei Liu, Tobias M. Hohl, Robert A. Cramer

Summary: This study identifies an important aspect of fungal biology in A. fumigatus that impacts susceptibility to leukocyte killing.

MSPHERE (2023)

Article Respiratory System

Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria An Official American Thoracic Society Workshop Report

Guang-Shing Cheng, Kristina Crothers, Stefano Aliberti, Anne Bergeron, Michael Boeckh, Jason W. Chien, Catia Cilloniz, Keira Cohen, Nathan Dean, Charles S. Dela Cruz, Robert P. Dickson, Alexander L. Greninger, Chadi A. Hage, Tobias M. Hohl, Steven M. Holland, Barbara E. Jones, Joseph Keane, Mark Metersky, Rachel Miller, Anne Puel, Julio Ramirez, Marcos Restrepo, Ajay Sheshadri, Bashar Staitieh, Jeffrey Tarrand, Kevin L. Winthrop, Richard G. Wunderink, Scott E. Evans

Summary: Pneumonia poses a clinical burden on immunocompromised individuals, who are often excluded from clinical guidelines and trials. The lack of a widely accepted definition for immunocompromised host pneumonia hampers consistent care and research. To address this, the American Thoracic Society convened a workshop to define immunocompromised host pneumonia and its diagnostic criteria.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2023)

Review Immunology

Immune responses to human fungal pathogens and therapeutic prospects

Michail S. S. Lionakis, Rebecca A. A. Drummond, Tobias M. M. Hohl

Summary: Pathogenic fungi have become major causes of infectious morbidity and mortality in patients with immunodeficiency conditions, and the spread of multidrug-resistant Candida auris has raised global public health concerns. Advances in understanding the cellular and molecular determinants of antifungal immunity provide potential strategies for risk stratification, prognosis, prophylaxis, and therapy against life-threatening fungal infections.

NATURE REVIEWS IMMUNOLOGY (2023)

Article Medicine, Research & Experimental

Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis

Deepika Awasthi, Sahil Chopra, Byuri A. Cho, Alexander Emmanuelli, Tito A. Sandoval, Sung-Min Hwang, Chang-Suk Chae, Camilla Salvagno, Chen Tan, Liliana Vasquez-Urbina, Jose J. Fernandez Rodriguez, Sara F. Santagostino, Takao Iwawaki, E. Alfonso Romero-Sandoval, Mariano Sanchez Crespo, Diana K. Morales, Iliyan D. Iliev, Tobias M. Hohl, Juan R. Cubillos-Ruiz

Summary: Infection with Candida albicans triggers hyperactivation of IRE1 alpha, leading to kidney immunopathology. Activation of MyD88 and dectin-1 by C. albicans causes ROS generation, ER stress, and overexpression of inflammatory mediators through IRE1 alpha. Inhibiting IRE1 alpha can mitigate inflammation and improve survival in systemic C. albicans infection.

JOURNAL OF CLINICAL INVESTIGATION (2023)

No Data Available